The Pharmaceutical Journal
Vol 274 No 7336 p168
12 February 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Shipman case pharmacist faces Statutory Committee

The pharmacist criticised during the Shipman Inquiry for not noticing abnormal prescribing that allowed Shipman to collect diamorphine which he then used to kill many patients, will appear before the Royal Pharmaceutical Society’s Statutory Committee on 21 and 22 February.

In the view of the Shipman Inquiry chairwoman, Dame Janet Smith, Ghislaine Brant had not fulfilled her professional obligations to scrutinise prescriptions to ensure that they were appropriate for patients or to watch out for signs that a doctor might be prescribing unlawfully or irresponsibly.

Mrs Brant had been the victim of deliberate deception by an accomplished liar, Dame Janet said.